Towards that end, the European Society for Medical Oncology (ESMO) has developed a new guidance document that outlines the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

TIOBE Index for November 2025: Top 10 Most Popular Programming Languages Your email has been sent November’s TIOBE Programming Community Index feels less like a simple reshuffle and more like a new ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

For French writer Laurent Binet, this seemingly innocuous (albeit tragic) accident was in fact a far more nefarious event, one that is the basis for his compelling new novel. In The 7th Function of ...